Hartree Partners LP 13D/13G Filings for IBERE PHARMACEUTICALS UNIT 1 C (IBERU)

Hartree Partners LP 13D and 13G filings for IBERE PHARMACEUTICALS UNIT 1 C:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-08
2:09 pm
Sale
2022-12-3113GIBERE PHARMACEUTICALS UNIT 1 C
IBERU
Hartree Partners LP0
0.000%
-1,285,000decrease
(Position Closed)
Filing
2021-09-27
2:36 pm
Purchase
2021-02-2613GIBERE PHARMACEUTICALS UNIT 1 C
IBERU
Hartree Partners LP1,285,000
9.300%
1,285,000increase
(New Position)
Filing